| 17beta-estradiol | decreases expression | ISO | RGD:1305462 | 6480464 | Estradiol results in decreased expression of GPT2 mRNA | CTD | PMID:20068009 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of GPT2 mRNA | CTD | PMID:20106945 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of GPT2 mRNA | CTD | PMID:20106945 PMID:21632981 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:1305462 | 6480464 | Tetrachlorodibenzodioxin affects the expression of GPT2 mRNA | CTD | PMID:22298810 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:1305462 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of GPT2 mRNA | CTD | PMID:21215274 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:1313503 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of GPT2 mRNA | CTD | PMID:19770486 |
| 2,4-dinitrotoluene | affects expression | ISO | RGD:1305462 | 6480464 | 2,4-dinitrotoluene affects the expression of GPT2 mRNA | CTD | PMID:21346803 |
| 3,3',4,4'-tetrachlorobiphenyl | multiple interactions | ISO | RGD:1313503 | 6480464 | 3,4,3',4'-tetrachlorobiphenyl inhibits the reaction [Dietary Fats results in increased expression of GPT2 mRNA] | CTD | PMID:19467301 |
| 4,4'-diaminodiphenylmethane | increases expression | ISO | RGD:1313503 | 6480464 | 4,4'-diaminodiphenylmethane results in increased expression of GPT2 mRNA | CTD | PMID:18648102 |
| arsenite(3-) | affects expression | EXP | | 6480464 | arsenite affects the expression of GPT2 mRNA | CTD | PMID:22959463 |
| benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of GPT2 mRNA | CTD | PMID:20064835 PMID:20106945 |
| benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of GPT2 mRNA | CTD | PMID:20064835 more ... |
| benzo[a]pyrene | decreases expression | ISO | RGD:1305462 | 6480464 | Benzo(a)pyrene results in decreased expression of GPT2 mRNA | CTD | PMID:21839799 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:1313503 | 6480464 | [Benzo(a)pyrene co-treated with XPA gene mutant form co-treated with TRP53 gene mutant form] results in decreased expression of GPT2 mRNA | CTD | PMID:21715664 |
| benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of GPT2 mRNA | CTD | PMID:20106945 PMID:20064835 |
| benzo[a]pyrene | decreases expression | ISO | RGD:1313503 | 6480464 | Benzo(a)pyrene results in decreased expression of GPT2 mRNA | CTD | PMID:19770486 |
| chloroprene | increases expression | ISO | RGD:1313503 | 6480464 | Chloroprene results in increased expression of GPT2 mRNA | CTD | PMID:23125180 |
| ciguatoxin CTX1B | affects expression | ISO | RGD:1313503 | 6480464 | Ciguatoxins affects the expression of GPT2 mRNA | CTD | PMID:18353800 |
| cobalt atom | multiple interactions | EXP | | 6480464 | [tungsten carbide co-treated with Cobalt] results in increased expression of GPT2 mRNA | CTD | PMID:23052192 |
| copper(2+) sulfate | affects expression | EXP | | 6480464 | Copper Sulfate affects the expression of GPT2 mRNA | CTD | PMID:19549813 |
| cyclosporin A | increases expression | EXP | | 6480464 | Cyclosporine results in increased expression of GPT2 mRNA | CTD | PMID:20106945 |
| cyclosporin A | decreases expression | ISO | RGD:1313503 | 6480464 | Cyclosporine results in decreased expression of GPT2 mRNA | CTD | PMID:19770486 |
| Delta(9)-tetrahydrocannabinol | increases expression | ISO | RGD:1313503 | 6480464 | Tetrahydrocannabinol results in increased expression of GPT2 mRNA | CTD | PMID:21542829 |
| hydrogen peroxide | affects expression | EXP | | 6480464 | Hydrogen Peroxide affects the expression of GPT2 mRNA | CTD | PMID:20044591 |
| hydrogen peroxide | increases expression | EXP | | 6480464 | Hydrogen Peroxide results in increased expression of GPT2 mRNA | CTD | PMID:18951874 |
| menadione | affects expression | EXP | | 6480464 | Vitamin K 3 affects the expression of GPT2 mRNA | CTD | PMID:20044591 |
| methotrexate | affects expression | ISO | RGD:1313503 | 6480464 | Methotrexate affects the expression of GPT2 mRNA | CTD | PMID:18502557 |
| N-methyl-4-phenylpyridinium | increases expression | ISO | RGD:1313503 | 6480464 | 1-Methyl-4-phenylpyridinium results in increased expression of GPT2 mRNA | CTD | PMID:22776087 |
| paracetamol | affects expression | ISO | RGD:1313503 | 6480464 | Acetaminophen affects the expression of GPT2 mRNA | CTD | PMID:17562736 |
| paracetamol | increases expression | ISO | RGD:1305462 | 6480464 | Acetaminophen results in increased expression of GPT2 protein | CTD | PMID:19085960 |
| paracetamol | increases activity | ISO | RGD:1305462 | 6480464 | Acetaminophen results in increased activity of GPT2 protein | CTD | PMID:19085960 |
| phenobarbital | increases expression | ISO | RGD:1313503 | 6480464 | Phenobarbital results in increased expression of GPT2 mRNA | CTD | PMID:19270015 |
| pirinixic acid | multiple interactions | EXP | | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of GPT2 mRNA | CTD | PMID:19710929 |
| pirinixic acid | increases expression | ISO | RGD:1313503 | 6480464 | pirinixic acid results in increased expression of GPT2 mRNA | CTD | PMID:18445702 |
| propiconazole | decreases expression | ISO | RGD:1313503 | 6480464 | propiconazole results in decreased expression of GPT2 mRNA | CTD | PMID:21278054 |
| quercetin | decreases expression | EXP | | 6480464 | Quercetin results in decreased expression of GPT2 mRNA | CTD | PMID:21632981 |
| tetrachloromethane | increases activity | ISO | RGD:1313503 | 6480464 | Carbon Tetrachloride results in increased activity of GPT2 protein | CTD | PMID:19085960 |
| tetrachloromethane | increases expression | ISO | RGD:1313503 | 6480464 | Carbon Tetrachloride results in increased expression of GPT2 protein | CTD | PMID:19085960 |
| valproic acid | affects expression | ISO | RGD:1313503 | 6480464 | Valproic Acid affects the expression of GPT2 mRNA | CTD | PMID:17292431 |